Alemtuzumab induces changes in the innate immune system in patients with relapsing-remitting multiple sclerosis

被引：0
|
作者：
Ladwig, A. [1 ]
Suh, J. [1 ]
Schweitzer, F. [1 ]
Roeth, P. [1 ]
Remke, G. [1 ]
Warnke, C. [1 ]
Schroeter, M. [1 ]
Izquierdo-Alvarez, E. [1 ]
Bonmann, E. [2 ]
Fink, G. R. [1 ]
Pallasch, C. [1 ]
Lehmann, H. [1 ]
机构：
[1] Univ Hosp Cologne, Cologne, Germany
[2] Merheim Hosp, Cologne, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0287
引用
收藏
页码：259 / 259
页数：1
相关论文
共 50 条
  • [1] Alemtuzumab induces severe orbitopathy in relapsing-remitting multiple sclerosis
    Gomez, Pablo Rodriguez de Vera
    Muros, Mariola Mendez
    Cuadro, Alberto Torres
    de Miera, Francisco Javier Toyos Saenz
    Ruiz, Rocio Lopez
    Vazquez, Raquel Guerrero
    Gonzalez, Juan Jesus Garcia
    Hermosilla, Antonio Manuel Garrido
    Hernandez, Tomas Martin
    JOURNAL OF NEUROLOGY, 2024, 271 (01) : 486 - 496
  • [2] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
  • [3] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
    Hersh, Carrie M.
    Cohen, Jeffrey A.
    IMMUNOTHERAPY, 2014, 6 (03) : 249 - 259
  • [4] Autoimmunity in patients treated with alemtuzumab for relapsing-remitting multiple sclerosis
    Fox, E. J.
    Arnold, D. L.
    Cohen, J.
    Coles, A. J.
    Confavreux, C.
    Hartung, H. -P.
    Havrdova, E.
    Selmaj, K.
    Weiner, H.
    Lake, S. L.
    Margolin, D. H.
    Oyuela, P.
    Panzara, M.
    Compston, D. A. S.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 465 - 466
  • [5] Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis
    Graves, Jennifer
    Galetta, Steven L.
    Palmer, Jeffrey
    Margolin, David H.
    Rizzo, Marco
    Bilbruck, John
    Balcer, Laura J.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (10) : 1302 - 1309
  • [6] The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
    Alroughani, Raed
    Van Wijmeersch, Bart
    Al Khaboori, Jabber
    Alsharoqi, Isa Ahmed
    Ahmed, Samar F.
    Hassan, Ali
    Inshasi, Jihad
    Krieger, Derk W.
    Shakra, Mustafa
    Shatila, Ahmed Osman
    Szolics, Miklos
    Khallaf, Mohamed
    Ezzat, Aly
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [7] Alemtuzumab Improves Contrast Sensitivity in Relapsing-Remitting Multiple Sclerosis Patients
    Balcer, Laura
    Galetta, Steven
    Maguire, Maureen
    Palmer, Jeffrey
    Margolin, David
    Rizzo, Marco
    NEUROLOGY, 2011, 76 (09) : A446 - A446
  • [8] Effect of alemtuzumab on quality of life in patients with relapsing-remitting multiple sclerosis
    Bass, Ann
    MULTIPLE SCLEROSIS, 2009, 15 (11): : 1396 - 1396
  • [9] Alemtuzumab: evidence for its potential in relapsing-remitting multiple sclerosis
    Brown, J. William L.
    Coles, Alasdair J.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 131 - 138
  • [10] COST-EFFECTIVENESS OF ALEMTUZUMAB FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Kohn, Christine G.
    Costales, Victoria
    Coleman, Craig I.
    Young, Dan
    Limone, Brendan L.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (10) : 1413 - 1414
12345